Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

The Diagnosis and Most-Updated Therapy of Migraine

Article information

J Korean Med Assoc. 2009;52(5):500-506
Publication date (electronic) : 2009 May 30
doi : https://doi.org/10.5124/jkma.2009.52.5.500
Kwang-Soo Lee, MD
Department of Neurology, The Catholic University of Korea College of Medicine, Korea. ks1007@catholic.ac.kr

Abstract

Migraine is a very common headache disorder. The international headache society subdivides migraine into the ones with and without aura. The migraine attack can consist of premonitory, aura, headache, and resolution phases. Diagnosis is based on the characteristics of headache and associated symptoms. There are many abortive and preventive migraine treatments. Abortive treatment is either specific for the disease or nonspecific such as analgesics. The migraine specific therapies are representative of new migraine abortive medications, which act as serotonin agonist-triptan and ergot. Stratified care and early treatment are also cost-effective. Increased headache frequency is an indication for a preventive treatment. Preventive treatment decreases migraine frequency and improves quality of life. More treatments are being developed. Several new treatments are reviewed in this article.

Keywords: Migraine; Aura; Triptan; Stratified care; Preventive treatment

References

1. Lipton RB, Stewart WF, Von Korff M. Burden of migraine: Societal costs and therapeutic opportunities. Neurology 1997. 48(S3)S4–S9.
2. Headache classification committee of the international headache society. Classification and diagnostic criteria for headche disorders, cranial neuralgia, and facial pain. Cephalagia 1988. 81–96.
3. Headache classification committee. The international classification of Headache disorders, 2nd edition. Cephalagia 2004. 241–160.
4. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartate. Arch Neurol Psychiatry 1938. 39737–763.
5. The guideline of migraine. korean J Headache 2008. 2nd edth ed. Seoul: 1–97.
6. Kim BK. Pathophysiological basis of migraine therapy. Korean J Headache 2005. 66–13.
7. Silberstein SD. Migraine The Lancet 2004. 363381–391.
8. Filippi M, Rocca MA. Headche and migraine. Neurol Sci 2008. 29S336–S338.
9. Moon HS. Acute treatment of migraine:triptans and beyond. Korean J headache 2005. 614–20.
10. Aguggia M. Treating headaches with botulinum toxin. Neurol Sci 2008. 29S137–S139.

Article information Continued

Copyright © 2009 Korean Medical Association

Figure 1

Figure 1

Pathophysiology of migraine (Neurovascular theory)

Table 1

Diagnostic criteria for migraine without aura

Table 1

Table 2

Indication for neuroimaging in migraine

Table 2

Table 3

Preventive treatment of migraine

Table 3

*Prevention for menstrual migraine

Table 4

Treatment of acute migraine

Table 4